S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ORIC Oric Pharmaceuticals Inc

7.66

0.00 (0.00%)

Pre Market

Last Updated: 03:00:00

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals Inc News

Form 8-K - Current report
Tuesday 25 February 2025 (1 week ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones
Tuesday 25 February 2025 (1 week ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 18 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 February 2025 (2 weeks ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
Tuesday 18 February 2025 (2 weeks ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 7 February 2025 (4 weeks ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Monday 27 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
Monday 13 January 2025 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
Monday 13 January 2025 (2 months ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 3 January 2025 (2 months ago) • GlobeNewswire Inc.

More Oric Pharmaceuticals Inc News Articles

BNP Paribas Issuance

Intesa Sanpaolo

Leonteq Securities

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions